Support
Davy
(Customer support)
Tawin
(Handling complaints)
>800 million
of products on Amazon
200.000 successful
transaction through Fado168
0885996168 086356168
0

Monistat 1 Day Yeast Infection Treatment for Women, 1 Miconazole Ovule Insert & External Monistat Anti-Itch Cream Bundle

0885996168

Monday to Friday: from 08h - 22h, including Saturday and Sunday

$28.6

Delivery time 15-20 day. View detail
The Product does not have an exact weight, The total order value may be changed after approval
Style:
Pattern Name:
Quantity:
Seller List
The Time commitment
Fado168.com offers flexible shipping packages
3-5 days 7-20 days
+ See the detail
Free customs procedures
Fado168.com represent the customers to handle all the paperworks from the stage of export from ASIA import to Cambodia
+ See the detail
Diversified payment, flexible
Transfer by Internet Banking, via Bank account, by Wing or pay direct at Company
+ See the detail
Free delivery
Free delivery in Phnom Penh
+ See the detail
Safe shopping
With Fado168.com buyers always have insurance the risk when order the international goods
+ See the detail
Loading Product Infomation...

 

PRODUCT FEATURES
  • MONISTAT 1 DAY TREATMENT: A yeast infection treatment for women that cures most yeast infections and reduces symptoms such as external irritation, itching, discharge, soreness, redness, and discomfort
  • YEAST INFECTION TREATMENT KIT: Contains 1 vaginal applicator with 1200 mg miconazole nitrate ovule insert and 1 tube of anti-itch fungal cream for external use
  • MONISTAT ITCH CREAM: An effective, external anti-itch cream for women, cooling and soothing irritated skin to provide relief
  • WORKS 4X FASTER: Monistat provides treatment for women experiencing yeast infection symptoms 4x faster than the leading prescription pill*; *Based on clinical study of Monistat 1-Dose Ovule Combination Pack versus fluconazole 150mg tablet
  • RECOMMENDED BY GYNECOLOGISTS: Monistat is the number 1 gynecologist-recommended brand in the over-the-counter vaginal antifungal category in the US among OB/GYNs**; **According to the ProVoice Survey, fielded to US/OB-GYNs from 1/1/24-12/31/24
Contact